BEIJING — China's latest list of drugs whose expenses will be partially reimbursed by the basic medical insurance system was implemented on March 1. 

A total of 119 drugs have been newly included in the list, with their prices dropping an average of 50.64 percent.

Drugs against chronic obstructive pulmonary disease, lupus erythematosus and depression are among the new additions.

Besides, medicines recommended by the latest national treatment protocol for COVID-19 patients have also been included in the reimbursement list.